Liposome‐Based Potential Vaccines Platforms that Are Noncytotoxic
Saïda Mebarek, Killian Jacob, Carmela Ilaria Pierro, D. Romanini et autres
Synthetic vaccines represent a promising avenue in cancer immunotherapy by promoting targeted immune responses. Liposomal technologies have further advanced synthetic vaccinology by enabling the efficient delivery of tumor-associated carbohydrate antigens. Despite this progress, the toxicity and reproducibility of such platforms remain underexplored. …
fr, it (code pays fourni par la source)